Allergy and Infectious Diseases Research in Maryland
Allergy and Infectious Diseases Research (93.855) awarded $1.2 billion to recipients in Maryland in 683 grants from fiscal 2021 to 2025, 5.5% of the program's national total. The Johns Hopkins University received the most, $669 million.
- Awarded in Maryland$1.2 billion
- Awards683
- Share of the program5.5%
- Rank among states6th of 52
- National total$22 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 338 | $264 million |
| FY 2022 | 313 | $235 million |
| FY 2023 | 324 | $239 million |
| FY 2024 | 335 | $217 million |
| FY 2025 | 307 | $249 million |
Recipients in Maryland
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Johns Hopkins University | Colleges and universities | 323 | $669 million |
| University of Maryland, Baltimore | Colleges and universities | 152 | $247 million |
| University of Maryland, College Park | Colleges and universities | 57 | $76.4 million |
| The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | Nonprofits | 29 | $55.5 million |
| Sanaria Inc. | Small businesses | 19 | $39.2 million |
| Abvacc, Inc. | Small businesses | 10 | $16.1 million |
| Scanogen Inc. | Small businesses | 5 | $13.7 million |
| Rise Therapeutics LLC | Small businesses | 4 | $8.9 million |
| Autonomous Therapeutics Inc | Small businesses | 3 | $7.7 million |
| Fzata Inc | Small businesses | 3 | $6.3 million |
Open opportunities under this program
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- Immune Tolerance Network (UM1 Clinical Trial Required)
- Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)
- NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed)
- Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)
See all 93 on the program page
Questions people ask
How much Allergy and Infectious Diseases Research money goes to Maryland?
$1.2 billion from fiscal 2021 to 2025, across 683 awards. Maryland ranks 6th of 52 states and territories for this program.
Who receives Allergy and Infectious Diseases Research money in Maryland?
The largest recipient is The Johns Hopkins University, with $669 million in 323 awards. Next are University of Maryland, Baltimore and University of Maryland, College Park.
Can organizations in Maryland apply now?
Yes, 93 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Allergy and Infectious Diseases Research in other states
Other large programs in Maryland
- Grants to States for Medicaid
- Greenhouse Gas Reduction Fund: National Clean Investment Fund
- Education Stabilization Fund
- Highway Planning and Construction
- USAID Foreign Assistance for Programs Overseas
- 1332 State Innovation Waivers
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- National School Lunch Program
- Children's Health Insurance Program
- Title I Grants to Local Educational Agencies